View of Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes

Return to Article Details Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes Download Download PDF